These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6250088)

  • 1. Enhanced behavioural, electrocortical and hyperthermic effects of serotonin-like agents after impairment of serotonin transmission in fowl brain.
    Nisticò G; Carruba MO; Rotiroti D; Naccari F
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):229-34. PubMed ID: 6250088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute central effects of 5,6-dihydroxytryptamine in fowl.
    Nisticó G; Gargiulo G; Rotiroti D; Preziosi P
    Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):267-71. PubMed ID: 984979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of central nervous system-acting drugs after selective destruction by neurotoxins of 5-hydroxytryptamine fibers in the brain.
    Carruba MO; Nisticò G; Gargiulo G
    Ann N Y Acad Sci; 1978 Jun; 305():242-58. PubMed ID: 309299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central effects of clonidine 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in fowls.
    Marley E
    Br J Pharmacol; 1975 Dec; 55(4):459-73. PubMed ID: 1212558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of catecholamines and adenosine derivatives given into the brain of fowls.
    Marley E; Nistico G
    Br J Pharmacol; 1972 Dec; 46(4):619-36. PubMed ID: 4347707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nicotine given into the brain of fowls.
    Marley E; Seller TJ
    Br J Pharmacol; 1974 Jul; 51(3):335-46. PubMed ID: 4615761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of muscarine given into the brain of fowls.
    Marley E; Seller TJ
    Br J Pharmacol; 1972 Mar; 44(3):413-34. PubMed ID: 5040659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptamines and some other substances affecting waking and sleep in fowls.
    Marley E; Nistiò G
    Br J Pharmacol; 1975 Feb; 53(2):193-205. PubMed ID: 1148481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic responses to direct and indirect 5-HT agonists in rabbits following induction of 5-HT receptor supersensitivity by pharmacological manipulations which either reduce or leave unmodified brain 5-HT stores.
    Carruba MO; Picotti GB; Calogero M; Negreanu J; Mantegazza P
    Pharmacol Res Commun; 1981 Sep; 13(8):807-15. PubMed ID: 6457307
    [No Abstract]   [Full Text] [Related]  

  • 10. Central effects of histamine and H1 and H2 receptors agonists and antagonists after intraventricular infusion in fowls.
    Nisticò G; Rotiroti D; De Sarro A; Naccari F; Stephenson JD
    Res Commun Chem Pathol Pharmacol; 1980 Mar; 27(3):431-50. PubMed ID: 6104348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intraventricular beta-endorphin and D-ALA2-methionine-enkephalinamide on behaviour, spectrum power of electrocortical activity and body temperature in chicks.
    Nisticõ G; Rotiroti D; Naccari F; De Sarro GB; Marmo E
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):295-308. PubMed ID: 7394325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural, electrocortical and body temperature effects of cholera toxin.
    Nisticò G; Stephenson JD; Preziosi P
    Eur J Pharmacol; 1976 Apr; 36(2):459-62. PubMed ID: 1278234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep suppressant action of fenfluramine in rats. II. Evidence against the involvement of presynaptic serotonergic mechanism.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):675-81. PubMed ID: 6223135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural and body temperature effects of meningococcal lipopolysaccharide after intraventricular injection in adult fowls Gallus domesticus.
    Rotiroti D; Focà A; Mastroeni P; Fumarola D; Nisticò G
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):395-402. PubMed ID: 6800001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
    Carlton J; Rowland N
    Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat.
    Iovino M; Steardo L
    Eur J Pharmacol; 1985 Jul; 113(1):99-103. PubMed ID: 2931284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a receptor supersensitivity following impairment of central serotoninergic activity in the rabbit.
    Carruba MO; Nisticó G; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(2):125-9. PubMed ID: 160509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
    Willoughby JO; Menadue M; Jervois P
    Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.